LSPN 19: AI ‘explosion’ and drug costs in Canada

Uncertainty surrounding the patentability of artificial intelligence (AI) and changes to patented medicine pricing in Canada were two topics discussed yesterday, October 15 at Life Sciences Patent Network Fall in San Francisco.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

LSPN Connect: Invention harvesting

14 September 2020 In the fast-paced environment of life sciences, the need for the IP sector to take full advantage of potential and emerging innovations is paramount, as a LSPN Connect session discovered.

Americas

LSPN 19: choose your IP strategy wisely, warn IP experts

24 October 2019 Choosing the right IP strategy is crucial for companies, but constrained budgets and picking the wrong partners are all factors that can steer companies off the correct path.

Americas

LSPN 19: PTAB and ‘languishing’ STRONGER Act on 2020 agenda

22 October 2019 While the next Alice or Mayo is unlikely to be handed down next year, there are many slightly less “revolutionary" developments likely to crop up in 2020, according to Charles Larsen, partner at White & Case.

More on this story

Biotechnology

LSPN Connect: Invention harvesting

Americas

LSPN 19: choose your IP strategy wisely, warn IP experts

24 October 2019 Choosing the right IP strategy is crucial for companies, but constrained budgets and picking the wrong partners are all factors that can steer companies off the correct path.

Americas

LSPN 19: PTAB and ‘languishing’ STRONGER Act on 2020 agenda

More on this story

Biotechnology

LSPN Connect: Invention harvesting

Americas

LSPN 19: choose your IP strategy wisely, warn IP experts

24 October 2019 Choosing the right IP strategy is crucial for companies, but constrained budgets and picking the wrong partners are all factors that can steer companies off the correct path.

Americas

LSPN 19: PTAB and ‘languishing’ STRONGER Act on 2020 agenda